San Diego, CA -- (SBWire) -- 08/23/2016 --An investigation on behalf of investors in shares of CytoDyn Inc (OTCMKTS:CYDY) was announced over potential breaches of fiduciary duties by certain directors at CytoDyn Inc.
Investors who purchased shares of CytoDyn Inc (OTCMKTS:CYDY) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.
The investigation by a law firm concerns whether certain CytoDyn directors breached their fiduciary duties and caused damage to the company and its shareholders.
Vancover, WA based CytoDyn Inc. is a clinical-stage biotechnology company that is focused on the clinical development and commercialization of humanized monoclonal antibodies to treat HIV infection. Shares of CytoDyn Inc (OTCMKTS:CYDY) closed on August 22, 2016 at $1.04 per share.
Those who purchased shares of CytoDyn Inc have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
Investigation for Investors in Shares of CytoDyn Inc (OTCMKTS:CYDY) Announced
An investigation on behalf of investors in CytoDyn Inc (OTCMKTS:CYDY) shares over potential wrongdoing at CytoDyn Inc was announced and OTCMKTS:CYDY stockholders should contact the Shareholders Foundation.